NCT01797341View on ClinicalTrials.gov

Prograf-Advagraf Cross Over Conversion Study

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Kidney-Pancreas Transplantation
Interventions
DRUG

Tacrolimus

DRUG

Tacrolimus

Trial Locations (1)

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01797341 - Prograf-Advagraf Cross Over Conversion Study | Biotech Hunter | Biotech Hunter